ROLE OF THE SPANISH AGENCY FOR MEDICINES AND MEDICAL DEVICES (AEMPS) IN THE ASSESSMENT OF CENTRALISED MEDICINAL PRODUCTS

被引：0
|
作者：
Alonso-Gutierrez, A. [1 ]
Sulleiro-Avendano, E. [1 ]
Padilla-Gallego, M. E. [1 ]
Diaz-Ramos, P. [1 ]
机构：
[1] Agencia Espanola Medicamentos & Prod Sanitarios, Madrid, Spain
来源：
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY | 2011年 / 109卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：51 / 51
页数：1
相关论文
共 50 条
  • [21] Adverse Drug Reactions in Children Reported to Croatian Agency for Medicinal Products and Medical Devices from 2005 to 2013
    Kolaric, D.
    Gvozdanovic, K.
    Sarinic, V. Macolic
    Krnic, D.
    DRUG SAFETY, 2013, 36 (09) : 919 - 919
  • [22] Biomarker and Companion Diagnostics-A Review of Medicinal Products Approved by the European Medicines Agency
    Orellana Garcia, Laura Patricia
    Ehmann, Falk
    Hines, Philip A.
    Ritzhaupt, Armin
    Brand, Angela
    FRONTIERS IN MEDICINE, 2021, 8
  • [23] Critical review on the Environmental Risk Assessment of medicinal products for human use in the centralised procedure
    Caneva, Laura
    Bonelli, Milton
    Papaluca-Amati, Marisa
    Vidal, Jean-Marc
    REGULATORY TOXICOLOGY AND PHARMACOLOGY, 2014, 68 (03) : 312 - 316
  • [24] Is it necessary to modify the normative of medical research when drugs are not the study objective? Response from the Spanish Agency of Medicines and Health Devices
    de la Fuente Honrubia, Cesar
    Macias Saint-Gerons, Diego
    Montero Corominas, Dolores
    MEDICINA CLINICA, 2012, 138 (12): : 546 - 547
  • [25] Medication Errors Detected Among the Spontaneously Reported Adverse Drug Reactions to the Croatian Agency for Medicinal Products and Medical Devices
    Sarinic, V. Macolic
    Kandzija, N.
    Pacadi, C.
    Mucalo, I.
    Hadziabdic, M. Ortner
    Krnic, D.
    Skvrce, N. Mirosevic
    DRUG SAFETY, 2015, 38 (10) : 940 - 940
  • [26] The European Medicines Evaluation Agency: Role of experts in drug assessment
    Benzi, G
    TRENDS IN PHARMACOLOGICAL SCIENCES, 1995, 16 (12) : 409 - 412
  • [27] EUROPEAN MEDICINES AGENCY'S GUIDELINE ON THE CLINICAL INVESTIGATION OF MEDICINAL PRODUCTS FOR THE TREATMENT OF RHEUMATOID ARTHRITIS
    Da Silva, D.
    Rook, E.
    Semis-Costa, N.
    Mueller-Berghaus, J.
    Vesely, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 828 - 828
  • [28] European medicines agency guideline for biological medicinal products: a further step for a safe use of biosimilars
    Carlo Agostini
    Giorgio Walter Canonica
    Enrico Maggi
    Clinical and Molecular Allergy, 13 (1)
  • [29] The European Medicines Agency Review of Ofatumumab (Arzerra®) for the Treatment of Chronic Lymphocytic Leukemia in Patients Refractory to Fludarabine and Alemtuzumab: Summary of the Scientific Assessment of the European Medicines Agency Committee for Medicinal Products for Human Use
    Gravanis, Iordanis
    Ersboll, Jens
    Skovlund, Eva
    Abadie, Eric
    Marty, Michel
    Pignatti, Francesco
    ONCOLOGIST, 2010, 15 (12): : 1335 - 1343
  • [30] The Difference between Approval Processes for Medicinal Products and Medical Devices in Europe
    Marshall, John
    Morrill, Kristine
    Gobbe, Marine
    Blanchard, Lauren
    OPHTHALMOLOGICA, 2021, 244 (05) : 368 - 378
12345